{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:50:07Z","timestamp":1794019807090,"version":"4.8.0"},"reference-count":160,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32201056"],"award-info":[{"award-number":["32201056"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82403915"],"award-info":[{"award-number":["82403915"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06473-8","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T10:41:03Z","timestamp":1744972863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["The G-quadruplex ligand CX-5461: an innovative candidate for disease treatment"],"prefix":"10.1186","volume":"23","author":[{"given":"Hong-Xia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Meng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pi-Jun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9564-0961","authenticated-orcid":false,"given":"Fang-Yuan","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,18]]},"reference":[{"key":"6473_CR1","doi-asserted-by":"publisher","first-page":"129016","DOI":"10.1016\/j.bmcl.2022.129016","volume":"77","author":"H Xu","year":"2022","unstructured":"Xu H, Hurley LH. A first-in-class clinical G-quadruplex-targeting drug. The bench-to-bedside translation of the fluoroquinolone QQ58 to CX-5461 (Pidnarulex). Bioorg Med Chem Lett. 2022;77:129016.","journal-title":"Bioorg Med Chem Lett"},{"key":"6473_CR2","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1158\/0008-5472.CAN-10-1728","volume":"71","author":"D Drygin","year":"2011","unstructured":"Drygin D, Lin A, Bliesath J, Ho CB, O\u2019Brien SE, Proffitt C, Omori M, Haddach M, Schwaebe MK, Siddiqui-Jain A, et al. Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal rna synthesis and solid tumor growth. Can Res. 2011;71:1418\u201330.","journal-title":"Can Res"},{"key":"6473_CR3","doi-asserted-by":"publisher","first-page":"18094","DOI":"10.18632\/oncotarget.4093","volume":"6","author":"SS Negi","year":"2015","unstructured":"Negi SS, Brown P. rRNA synthesis inhibitor, CX-5461, activates ATM\/ATR pathway in acute lymphoblastic leukemia, arrests cells in G2 phase and induces apoptosis. Oncotarget. 2015;6:18094\u2013104.","journal-title":"Oncotarget"},{"key":"6473_CR4","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/onc.2015.147","volume":"35","author":"F Scala","year":"2016","unstructured":"Scala F, Brighenti E, Govoni M, Imbrogno E, Fornari F, Trer\u00e9 D, Montanaro L, Derenzini M. Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate. Oncogene. 2016;35:977\u201389.","journal-title":"Oncogene"},{"key":"6473_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ccr.2012.05.019","volume":"22","author":"MJ Bywater","year":"2012","unstructured":"Bywater MJ, Poortinga G, Sanij E, Hein N, Peck A, Cullinane C, Wall M, Cluse L, Drygin D, Anderes K, et al. Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53. Cancer Cell. 2012;22:51\u201365.","journal-title":"Cancer Cell"},{"key":"6473_CR6","doi-asserted-by":"publisher","first-page":"14432","DOI":"10.1038\/ncomms14432","volume":"8","author":"H Xu","year":"2017","unstructured":"Xu H, Di Antonio M, McKinney S, Mathew V, Ho B, O\u2019Neil NJ, Santos ND, Silvester J, Wei V, Garcia J, et al. CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1\/2 deficient tumours. Nat Commun. 2017;8:14432.","journal-title":"Nat Commun"},{"key":"6473_CR7","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1021\/acs.jcim.0c00632","volume":"60","author":"H-J Sullivan","year":"2020","unstructured":"Sullivan H-J, Chen B, Wu C. Molecular dynamics study on the binding of an anticancer DNA G-quadruplex stabilizer, CX-5461, to Human telomeric, c-KIT1, and c-Myc G-quadruplexes and a DNA duplex. J Chem Inf Model. 2020;60:5203\u201324.","journal-title":"J Chem Inf Model"},{"key":"6473_CR8","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1021\/jacs.3c09074","volume":"146","author":"YS Zhang","year":"2024","unstructured":"Zhang YS, Cheng YL, Luo Q, Wu TB, Huo JF, Yin M, Peng H, Xiao Y, Tong QY, You HJ. Distinguishing G-quadruplexes stabilizer and chaperone for c-MYC promoter G-quadruplexes through single-molecule manipulation. J Am Chem Soc. 2024;146:3689\u201399.","journal-title":"J Am Chem Soc"},{"key":"6473_CR9","doi-asserted-by":"publisher","first-page":"6557","DOI":"10.1007\/s00018-021-03921-8","volume":"78","author":"FY Teng","year":"2021","unstructured":"Teng FY, Jiang ZZ, Guo M, Tan XZ, Chen F, Xi XG, Xu Y. G-quadruplex DNA: a novel target for drug design. Cell Mol Life Sci. 2021;78:6557\u201383.","journal-title":"Cell Mol Life Sci"},{"key":"6473_CR10","doi-asserted-by":"publisher","first-page":"107431","DOI":"10.1016\/j.phrs.2024.107431","volume":"209","author":"AD Bondarev","year":"2024","unstructured":"Bondarev AD, Jonsson J, Chubarev VN, Tarasov VV, Lagunas-Rangel FA, Schi\u00f6th HB. Recent developments of topoisomerase inhibitors: clinical trials, emerging indications, novel molecules and global sales. Pharmacol Res. 2024;209:107431.","journal-title":"Pharmacol Res"},{"key":"6473_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3390\/cells9020266","volume":"9","author":"R Ferreira","year":"2020","unstructured":"Ferreira R, Schneekloth J, Panov KI, Hannan KM, Hannan RD. Targeting the RNA polymerase I transcription for cancer therapy comes of age. Cells. 2020;9:266.","journal-title":"Cells"},{"issue":"87","key":"6473_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-biochem-062917-012612","volume":"87","author":"S Sharifi","year":"2018","unstructured":"Sharifi S, Bierhoff H. Regulation of RNA polymerase I transcription in development, disease, and aging. Annu Rev Biochem. 2018;87(87):51\u201373.","journal-title":"Annu Rev Biochem"},{"key":"6473_CR13","doi-asserted-by":"publisher","first-page":"e1705","DOI":"10.1002\/ctm2.1705","volume":"14","author":"L Cui","year":"2024","unstructured":"Cui L, Zheng JR, Lin YF, Lin P, Lu Y, Zheng YC, Guo B, Zhao XY. Decoding the ribosome\u2019s hidden language: rRNA modifications as key players in cancer dynamics and targeted therapies. Clin Transl Med. 2024;14:e1705.","journal-title":"Clin Transl Med"},{"key":"6473_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semcdb.2023.01.003","volume":"154","author":"B Cohen","year":"2024","unstructured":"Cohen B, Golani-Armon A, Arava YS. Emerging implications for ribosomes in proximity to mitochondria. Semin Cell Dev Biol. 2024;154:123\u201330.","journal-title":"Semin Cell Dev Biol"},{"key":"6473_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2024.10.001","author":"I Milenkovic","year":"2024","unstructured":"Milenkovic I, Novoa EM. Dynamic rRNA modifications as a source of ribosome heterogeneity. Trends Cell Biol. 2024. https:\/\/doi.org\/10.1016\/j.tcb.2024.10.001.","journal-title":"Trends Cell Biol"},{"key":"6473_CR16","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1158\/0008-5472.CAN-21-4087","volume":"82","author":"AR Elhamamsy","year":"2022","unstructured":"Elhamamsy AR, Metge BJ, Alsheikh HA, Shevde LA, Samant RS. Ribosome biogenesis: a central player in cancer metastasis and therapeutic resistance. Can Res. 2022;82:2344\u201353.","journal-title":"Can Res"},{"key":"6473_CR17","doi-asserted-by":"publisher","first-page":"21533","DOI":"10.1038\/s41598-021-00958-4","volume":"11","author":"K Morotomi-Yano","year":"2021","unstructured":"Morotomi-Yano K, Yano K. Nucleolar translocation of human DNA topoisomerase II by ATP depletion and its disruption by the RNA polymerase I inhibitor BMH-21. Sci Rep. 2021;11:21533.","journal-title":"Sci Rep"},{"key":"6473_CR18","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.3390\/cancers14092126","volume":"14","author":"A Zisi","year":"2022","unstructured":"Zisi A, Bartek J, Lindstr\u00f6m MS. Targeting ribosome biogenesis in cancer: lessons learned and way forward. Cancers. 2022;14:2126.","journal-title":"Cancers"},{"key":"6473_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/10408398.2023.2271101","volume":"65","author":"M Garofalo","year":"2025","unstructured":"Garofalo M, Payros D, Taieb F, Oswald E, Nougayr\u00e8de JP, Oswald IP. From ribosome to ribotoxins: understanding the toxicity of deoxynivalenol and Shiga toxin, two food borne toxins. Crit Rev Food Sci Nutr. 2025;65:193\u2013205.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"6473_CR20","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.chembiol.2018.09.010","volume":"25","author":"JD Mortison","year":"2018","unstructured":"Mortison JD, Schenone M, Myers JA, Zhang ZY, Chen LF, Ciarlo C, Comer E, Natchiar SK, Carr SA, Klaholz BP, et al. Tetracyclines modify translation by targeting key human rRNA substructures. Cell Chem Biol. 2018;25:1506.","journal-title":"Cell Chem Biol"},{"key":"6473_CR21","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1038\/s41467-021-23068-1","volume":"12","author":"MS Svetlov","year":"2021","unstructured":"Svetlov MS, Koller TO, Meydan S, Shankar V, Klepacki D, Polacek N, Guydosh NR, V\u00e1zquez-Laslop N, Wilson DN, Mankin AS. Context-specific action of macrolide antibiotics on the eukaryotic ribosome. Nat Commun. 2021;12:2803.","journal-title":"Nat Commun"},{"key":"6473_CR22","doi-asserted-by":"publisher","first-page":"zcaa032","DOI":"10.1093\/narcan\/zcaa032","volume":"2","author":"J-C Mars","year":"2020","unstructured":"Mars J-C, Tremblay MG, Valere M, Sibai DS, Sabourin-Felix M, Lessard F, Moss T. The chemotherapeutic agent CX-5461 irreversibly blocks RNA polymerase I initiation and promoter release to cause nucleolar disruption, DNA damage and cell inviability. NAR Cancer. 2020;2:zcaa032.","journal-title":"NAR Cancer"},{"key":"6473_CR23","doi-asserted-by":"publisher","first-page":"34846","DOI":"10.18632\/oncotarget.5413","volume":"6","author":"SS Negi","year":"2015","unstructured":"Negi SS, Brown P. Transient rRNA synthesis inhibition with CX-5461 is sufficient to elicit growth arrest and cell death in acute lymphoblastic leukemia cells. Oncotarget. 2015;6:34846\u201358.","journal-title":"Oncotarget"},{"key":"6473_CR24","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1182\/blood-2016-05-718171","volume":"129","author":"N Hein","year":"2017","unstructured":"Hein N, Cameron DP, Hannan KM, Nguyen NYN, Fong CY, Sornkom J, Wall M, Pavy M, Cullinane C, Diesch J, et al. Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population. Blood. 2017;129:2882\u201395.","journal-title":"Blood"},{"key":"6473_CR25","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1080\/09168451.2020.1801378","volume":"84","author":"S Okamoto","year":"2020","unstructured":"Okamoto S, Miyano K, Kajikawa M, Yamauchi A, Kuribayashi F. The rRNA synthesis inhibitor CX-5461 may induce autophagy that inhibits anticancer drug-induced cell damage to leukemia cells. Biosci Biotechnol Biochem. 2020;84:2319\u201326.","journal-title":"Biosci Biotechnol Biochem"},{"key":"6473_CR26","doi-asserted-by":"publisher","first-page":"e2206098","DOI":"10.1002\/advs.202206098","volume":"10","author":"J Xu","year":"2023","unstructured":"Xu J, Zhong AL, Zhang S, Chen M, Zhang LX, Hang XH, Zheng JA, Wu BH, Deng XT, Pan XY, et al. KMT2D deficiency promotes myeloid leukemias which is vulnerable to ribosome biogenesis inhibition. Adv Sci. 2023;10:e2206098.","journal-title":"Adv Sci"},{"key":"6473_CR27","doi-asserted-by":"publisher","first-page":"eadj8803","DOI":"10.1126\/sciadv.adj8803","volume":"10","author":"K Behrens","year":"2024","unstructured":"Behrens K, Brajanovski N, Xu Z, Viney EM, Dirago L, Hediyeh-Zadeh S, Davis MJ, Pearson RB, Sanij E, Alexander WS, et al. ERG and c-MYC regulate a critical gene network in BCR::ABL1-driven B cell acute lymphoblastic leukemia. Sci Adv. 2024;10:eadj8803.","journal-title":"Sci Adv"},{"key":"6473_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1158\/2159-8290.CD-14-0673","volume":"6","author":"JR Devlin","year":"2016","unstructured":"Devlin JR, Hannan KM, Hein N, Cullinane C, Kusnadi E, Ng PY, George AJ, Shortt J, Bywater MJ, Poortinga G, et al. Combination therapy targeting ribosome biogenesis and mRNA translation synergistically extends survival in MYC-driven lymphoma. Cancer Discov. 2016;6:59\u201370.","journal-title":"Cancer Discov"},{"key":"6473_CR29","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1073\/pnas.1921649117","volume":"117","author":"PM Bruno","year":"2020","unstructured":"Bruno PM, Lu MR, Dennis KA, Inam H, Moore CJ, Sheehe J, Elledge SJ, Hemann MT, Pritchard JR. The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoning. Proc Natl Acad Sci USA. 2020;117:4053\u201360.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6473_CR30","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3390\/biomedicines12071514","volume":"12","author":"DP Cameron","year":"2024","unstructured":"Cameron DP, Sornkom J, Alsahafi S, Drygin D, Poortinga G, Mcarthur GA, Hein N, Hannan R, Panov KI. CX-5461 preferentially induces Top2\u03b1-dependent DNA breaks at ribosomal DNA loci. Biomedicines. 2024;12:1514.","journal-title":"Biomedicines"},{"key":"6473_CR31","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s42003-024-06602-x","volume":"7","author":"H Lin","year":"2024","unstructured":"Lin H, Safdar MH, Washburn S, Akhand SS, Dickerhoff J, Ayers M, Monteiro M, Solorio L, Yang DZ, Wendt MK. Fibroblast growth receptor 1 is regulated by G-quadruplex in metastatic breast cancer. Commun Biol. 2024;7:963.","journal-title":"Commun Biol"},{"key":"6473_CR32","doi-asserted-by":"publisher","first-page":"5782","DOI":"10.3390\/ijms22115782","volume":"22","author":"A Makhale","year":"2021","unstructured":"Makhale A, Nanayakkara D, Raninga P, Khanna KK, Kalimutho M. CX-5461 enhances the efficacy of APR-246 via induction of DNA damage and replication stress in triple-negative breast cancer. Int J Mol Sci. 2021;22:5782.","journal-title":"Int J Mol Sci"},{"key":"6473_CR33","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1158\/1535-7163.MCT-20-0932","volume":"20","author":"MG Lawrence","year":"2021","unstructured":"Lawrence MG, Porter LH, Choo N, Pook D, Grummet JP, Pezaro CJ, Sandhu S, Ramm S, Luu J, Bakshi A, et al. CX-5461 sensitizes DNA damage repair\u2013proficient castrate-resistant prostate cancer to PARP inhibition. Mol Cancer Ther. 2021;20:2140\u201350.","journal-title":"Mol Cancer Ther"},{"key":"6473_CR34","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.eururo.2018.06.020","volume":"74","author":"MG Lawrence","year":"2018","unstructured":"Lawrence MG, Obinata D, Sandhu S, Selth LA, Wong SQ, Porter LH, Lister N, Pook D, Pezaro CJ, Goode DL, et al. Patient-derived models of abiraterone- and enzalutamide-resistant prostate cancer reveal sensitivity to ribosome-directed therapy. Eur Urol. 2018;74:562\u201372.","journal-title":"Eur Urol"},{"key":"6473_CR35","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.1158\/1078-0432.CCR-16-0124","volume":"22","author":"RJ Rebello","year":"2016","unstructured":"Rebello RJ, Kusnadi E, Cameron DP, Pearson HB, Lesmana A, Devlin JR, Drygin D, Clark AK, Porter L, Pedersen J, et al. The dual inhibition of RNA Pol I transcription and PIM kinase as a new therapeutic approach to treat advanced prostate cancer. Clin Cancer Res. 2016;22:5539\u201352.","journal-title":"Clin Cancer Res"},{"key":"6473_CR36","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41416-020-01158-z","volume":"124","author":"S Yan","year":"2020","unstructured":"Yan S, Xuan J, Brajanovski N, Tancock MRC, Madhamshettiwar PB, Simpson KJ, Ellis S, Kang J, Cullinane C, Sheppard KE, et al. The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancer. Br J Cancer. 2020;124:616\u201327.","journal-title":"Br J Cancer"},{"key":"6473_CR37","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.3390\/cancers13205056","volume":"13","author":"R Cornelison","year":"2021","unstructured":"Cornelison R, Biswas K, Llaneza DC, Harris AR, Sosale NG, Lazzara MJ, Landen CN. CX-5461 treatment leads to cytosolic DNA-mediated STING activation in ovarian cancer. Cancers. 2021;13:5056.","journal-title":"Cancers"},{"key":"6473_CR38","doi-asserted-by":"publisher","first-page":"1805256","DOI":"10.1080\/23723556.2020.1805256","volume":"7","author":"J Xuan","year":"2020","unstructured":"Xuan J, Pearson RB, Sanij E. CX-5461 can destabilize replication forks in PARP inhibitor-resistant models of ovarian cancer. Mol Cell Oncol. 2020;7:1805256.","journal-title":"Mol Cell Oncol"},{"key":"6473_CR39","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1038\/s41467-020-16393-4","volume":"11","author":"E Sanij","year":"2020","unstructured":"Sanij E, Hannan KM, Xuan J, Yan S, Ahern JE, Trigos AS, Brajanovski N, Son J, Chan KT, Kondrashova O, et al. CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer. Nat Commun. 2020;11:2641.","journal-title":"Nat Commun"},{"key":"6473_CR40","doi-asserted-by":"publisher","first-page":"6529","DOI":"10.1158\/1078-0432.CCR-17-0282","volume":"23","author":"R Cornelison","year":"2017","unstructured":"Cornelison R, Dobbin ZC, Katre AA, Jeong DH, Zhang YF, Chen DQ, Petrova Y, Llaneza DC, Steg AD, Parsons L, et al. Targeting RNA-polymerase I in both chemosensitive and chemoresistant populations in epithelial ovarian cancer. Clin Cancer Res. 2017;23:6529\u201340.","journal-title":"Clin Cancer Res"},{"key":"6473_CR41","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1158\/2159-8290.CD-18-1455","volume":"9","author":"A Khot","year":"2019","unstructured":"Khot A, Brajanovski N, Cameron DP, Hein N, Maclachlan KH, Sanij E, Lim J, Soong J, Link E, Blombery P, et al. First-in-human RNA polymerase I transcription inhibitor CX-5461 in patients with advanced hematologic cancers: results of a phase I dose-escalation study. Cancer Discov. 2019;9:1036\u201349.","journal-title":"Cancer Discov"},{"key":"6473_CR42","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1038\/s41467-022-31199-2","volume":"13","author":"J Hilton","year":"2022","unstructured":"Hilton J, Gelmon K, Bedard PL, Tu D, Xu H, Tinker AV, Goodwin R, Laurie SA, Jonker D, Hansen AR, et al. Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies. Nat Commun. 2022;13:3607.","journal-title":"Nat Commun"},{"key":"6473_CR43","doi-asserted-by":"publisher","first-page":"49800","DOI":"10.18632\/oncotarget.10452","volume":"7","author":"J Quin","year":"2016","unstructured":"Quin J, Chan KT, Devlin JR, Cameron DP, Diesch J, Cullinane C, Ahern J, Khot A, Hein N, George AJ, et al. Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM\/ATR signaling. Oncotarget. 2016;7:49800\u201318.","journal-title":"Oncotarget"},{"key":"6473_CR44","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/bjh.14525","volume":"177","author":"HC Lee","year":"2017","unstructured":"Lee HC, Wang H, Baladandayuthapani V, Lin H, He J, Jones RJ, Kuiatse I, Gu DM, Wang ZQ, Ma WC, et al. RNA polymerase I inhibition with CX-5461 as a novel therapeutic strategy to target MYC in multiple myeloma. Br J Haematol. 2017;177:80\u201394.","journal-title":"Br J Haematol"},{"key":"6473_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1182\/blood.2019003439","volume":"137","author":"S Le Goff","year":"2021","unstructured":"Le Goff S, Boussaid I, Floquet C, Raimbault A, Hatin I, Andrieu-Soler C, Salma M, Leduc M, Gautier E-F, Guyot B, et al. p53 activation during ribosome biogenesis regulates normal erythroid differentiation. Blood. 2021;137:89\u2013102.","journal-title":"Blood"},{"key":"6473_CR46","doi-asserted-by":"publisher","first-page":"5985","DOI":"10.2147\/OTT.S104513","volume":"9","author":"LM Li","year":"2016","unstructured":"Li LM, Li Y, Zhao JS, Fan SL, Wang LG, Li X. CX-5461 induces autophagy and inhibits tumor growth via mammalian target of rapamycin-related signaling pathways in osteosarcoma. Onco Targets Ther. 2016;9:5985\u201397.","journal-title":"Onco Targets Ther"},{"key":"6473_CR47","doi-asserted-by":"publisher","first-page":"111167","DOI":"10.1016\/j.intimp.2023.111167","volume":"125","author":"X Cui","year":"2023","unstructured":"Cui X, Li C-G, Gao H, Cheng M, Jiang F. Boosting regulatory T cell-dependent immune tolerance by activation of p53. Int Immunopharmacol. 2023;125:111167.","journal-title":"Int Immunopharmacol"},{"key":"6473_CR48","doi-asserted-by":"publisher","first-page":"174303","DOI":"10.1016\/j.ejphar.2021.174303","volume":"907","author":"S Pang","year":"2021","unstructured":"Pang S, Chen Y, Dai C, Liu T, Zhang W, Wang J, Cui X, Guo X, Jiang F. Anti-fibrotic effects of p53 activation induced by RNA polymerase I inhibitor in primary cardiac fibroblasts. Eur J Pharmacol. 2021;907:174303.","journal-title":"Eur J Pharmacol"},{"key":"6473_CR49","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1111\/bph.15385","volume":"178","author":"X Xu","year":"2021","unstructured":"Xu X, Feng H, Dai CC, Lu WD, Zhang J, Guo XS, Yin QH, Wang JL, Cui XP, Jiang F. Therapeutic efficacy of the novel selective RNA polymerase I inhibitor CX-5461 on pulmonary arterial hypertension and associated vascular remodelling. Br J Pharmacol. 2021;178:1605\u201319.","journal-title":"Br J Pharmacol"},{"key":"6473_CR50","doi-asserted-by":"publisher","first-page":"e37227","DOI":"10.1016\/j.heliyon.2024.e37227","volume":"10","author":"T Liu","year":"2024","unstructured":"Liu T, Pan G, Zhang J, Wang J, Guo X, Chen Y, Wang X, Cui X, Liu H, Jiang F. Molecular basis of CX-5461-induced DNA damage response in primary vascular smooth muscle cells. Heliyon. 2024;10:e37227.","journal-title":"Heliyon"},{"key":"6473_CR51","doi-asserted-by":"publisher","first-page":"7064319","DOI":"10.1155\/2019\/7064319","volume":"2019","author":"Q Wu","year":"2019","unstructured":"Wu Q, Hong JM, Wang ZW, Hu JX, Chen RS, Hu ZP, Li BW, Hu XP, Zhang ZP, Ruan YL. Abnormal ribosome biogenesis partly induced p53-dependent aortic medial smooth muscle cell apoptosis and oxidative stress. Oxid Med Cell Longev. 2019;2019:7064319.","journal-title":"Oxid Med Cell Longev"},{"key":"6473_CR52","doi-asserted-by":"publisher","first-page":"5930","DOI":"10.1128\/MCB.20.16.5930-5938.2000","volume":"20","author":"W Zhai","year":"2023","unstructured":"Zhai W, Comai L. Repression of RNA polymerase i transcription by the tumor suppressor p53. Mol Cell Biol. 2023;20:5930\u20138.","journal-title":"Mol Cell Biol"},{"key":"6473_CR53","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.1038\/onc.2015.25","volume":"34","author":"V Marcel","year":"2015","unstructured":"Marcel V, Catez F, Diaz JJ. p53, a translational regulator: contribution to its tumour-suppressor activity. Oncogene. 2015;34:5513\u201323.","journal-title":"Oncogene"},{"key":"6473_CR54","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.3390\/ijms20112718","volume":"20","author":"M Piazzi","year":"2019","unstructured":"Piazzi M, Bavelloni A, Gallo A, Faenza I, Blalock WL. Signal transduction in ribosome biogenesis: a recipe to avoid disaster. Int J Mol Sci. 2019;20:2718.","journal-title":"Int J Mol Sci"},{"key":"6473_CR55","doi-asserted-by":"publisher","first-page":"166719","DOI":"10.1016\/j.jmb.2020.11.018","volume":"433","author":"DP Dannheisig","year":"2021","unstructured":"Dannheisig DP, B\u00e4chle J, Tasic J, Keil M, Pfister AS. The Wnt\/\u03b2-catenin pathway is activated as a novel nucleolar stress response. J Mol Biol. 2021;433:166719.","journal-title":"J Mol Biol"},{"key":"6473_CR56","doi-asserted-by":"publisher","first-page":"123281","DOI":"10.1016\/j.ijbiomac.2023.123281","volume":"231","author":"D Bai","year":"2023","unstructured":"Bai D, Shan S-W, Zhang X, Li Y, Xie J, Wu W-Q. Comprehensive insights into the structures and dynamics of plant telomeric G-quadruplexes. Int J Biol Macromol. 2023;231:123281.","journal-title":"Int J Biol Macromol"},{"key":"6473_CR57","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.tibs.2023.06.007","volume":"48","author":"YC Dai","year":"2023","unstructured":"Dai YC, Teng XC, Zhang QS, Hou HW, Li JH. Advances and challenges in identifying and characterizing G-quadruplex-protein interactions. Trends Biochem Sci. 2023;48:894\u2013909.","journal-title":"Trends Biochem Sci"},{"key":"6473_CR58","first-page":"771","volume":"17","author":"S Iachettini","year":"2024","unstructured":"Iachettini S, Biroccio A, Zizza P. Therapeutic use of G4-ligands in cancer: state-of-the-art and future perspectives. Pharm Base. 2024;17:771.","journal-title":"Pharm Base"},{"key":"6473_CR59","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/nbt.3295","volume":"33","author":"VS Chambers","year":"2015","unstructured":"Chambers VS, Marsico G, Boutell JM, Di Antonio M, Smith GP, Balasubramanian S. High-throughput sequencing of DNA G-quadruplex structures in the human genome. Nat Biotechnol. 2015;33:877\u201381.","journal-title":"Nat Biotechnol"},{"key":"6473_CR60","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/nmeth.3965","volume":"13","author":"CK Kwok","year":"2016","unstructured":"Kwok CK, Marsico G, Sahakyan AB, Chambers VS, Balasubramanian S. rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome. Nat Methods. 2016;13:841\u20134.","journal-title":"Nat Methods"},{"key":"6473_CR61","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.1038\/s41467-021-25170-w","volume":"12","author":"X Chen","year":"2021","unstructured":"Chen X, Yuan J, Xue G, Campanario S, Wang D, Wang W, Mou X, Liew SW, Umar MI, Isern J, et al. Translational control by DHX36 binding to 5\u2032UTR G-quadruplex is essential for muscle stem-cell regenerative functions. Nat Commun. 2021;12:5043.","journal-title":"Nat Commun"},{"key":"6473_CR62","doi-asserted-by":"publisher","first-page":"e202203553","DOI":"10.1002\/anie.202203553","volume":"61","author":"K Lyu","year":"2022","unstructured":"Lyu K, Chen SB, Chow EYC, Zhao HZ, Yuan JH, Cai M, Shi JH, Chan TF, Tan JH, Kwok CK. An RNA G-quadruplex structure within the ADAR 5\u2032UTR interacts with DHX36 helicase to regulate translation. Angew Chem Int Edit. 2022;61:e202203553.","journal-title":"Angew Chem Int Edit"},{"key":"6473_CR63","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature13485","volume":"513","author":"AL Wolfe","year":"2014","unstructured":"Wolfe AL, Singh K, Zhong Y, Drewe P, Rajasekhar VK, Sanghvi VR, Mavrakis KJ, Jiang M, Roderick JE, Van der Meulen J, et al. RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer. Nature. 2014;513:65\u201370.","journal-title":"Nature"},{"key":"6473_CR64","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1093\/nar\/gkw006","volume":"44","author":"A Bedrat","year":"2016","unstructured":"Bedrat A, Lacroix L, Mergny J-L. Re-evaluation of G-quadruplex propensity with G4Hunter. Nucleic Acids Res. 2016;44:1746\u201359.","journal-title":"Nucleic Acids Res"},{"key":"6473_CR65","doi-asserted-by":"publisher","first-page":"e14265","DOI":"10.1111\/acel.14265","volume":"23","author":"KK Yu","year":"2024","unstructured":"Yu KK, Li FF, Ye L, Yu FY. Accumulation of DNA G-quadruplex in mitochondrial genome hallmarks mesenchymal senescence. Aging Cell. 2024;23:e14265.","journal-title":"Aging Cell"},{"key":"6473_CR66","doi-asserted-by":"publisher","first-page":"129337","DOI":"10.1016\/j.ijbiomac.2024.129337","volume":"259","author":"B Zhang","year":"2024","unstructured":"Zhang B, Sun R, Bai R, Sun Z, Liu R, Li W, Yao L, Sun H, Tang Y. G-quadruplex in mitochondria as a possible biomarker for mitophagy detection. Int J Biol Macromol. 2024;259:129337.","journal-title":"Int J Biol Macromol"},{"key":"6473_CR67","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.jmb.2019.03.010","volume":"431","author":"S Mestre-Fos","year":"2019","unstructured":"Mestre-Fos S, Penev PI, Suttapitugsakul S, Hu M, Ito C, Petrov AS, Wartell RM, Wu R, Williams LD. G-Quadruplexes in human ribosomal RNA. J Mol Biol. 2019;431:1940\u201355.","journal-title":"J Mol Biol"},{"key":"6473_CR68","doi-asserted-by":"publisher","first-page":"14855","DOI":"10.1074\/jbc.RA120.014332","volume":"295","author":"S Mestre-Fos","year":"2020","unstructured":"Mestre-Fos S, Ito C, Moore CM, Reddi AR, Williams LD. Human ribosomal G-quadruplexes regulate heme bioavailability. J Biol Chem. 2020;295:14855\u201365.","journal-title":"J Biol Chem"},{"key":"6473_CR69","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13578-023-01074-8","volume":"13","author":"ZH Zhang","year":"2023","unstructured":"Zhang ZH, Qian SH, Wei DG, Chen ZX. In vivo dynamics and regulation of DNA G-quadruplex structures in mammals. Cell Biosci. 2023;13:117.","journal-title":"Cell Biosci"},{"key":"6473_CR70","first-page":"769","volume":"14","author":"T Santos","year":"2021","unstructured":"Santos T, Salgado GF, Cabrita EJ, Cruz C. G-quadruplexes and their ligands: biophysical methods to unravel G-quadruplex\/ligand interactions. Pharm Base. 2021;14:769.","journal-title":"Pharm Base"},{"key":"6473_CR71","doi-asserted-by":"publisher","first-page":"129384","DOI":"10.1016\/j.bmcl.2023.129384","volume":"91","author":"MY Jin","year":"2023","unstructured":"Jin MY, Hurley LH, Xu H. A synthetic lethal approach to drug targeting of G-quadruplexes based on CX-5461. Bioorg Med Chem Lett. 2023;91:129384.","journal-title":"Bioorg Med Chem Lett"},{"key":"6473_CR72","doi-asserted-by":"publisher","first-page":"5859","DOI":"10.1021\/acs.jpcb.3c03031","volume":"127","author":"T Liu","year":"2023","unstructured":"Liu T, Wu Y, Qin L, Luo Q, Li W, Cheng Y, Tu Y, You H. Nonselective intercalation of G-quadruplex-targeting ligands into double-stranded DNA quantified by single-molecule stretching. J Phys Chem B. 2023;127:5859\u201368.","journal-title":"J Phys Chem B"},{"key":"6473_CR73","doi-asserted-by":"publisher","first-page":"180","DOI":"10.52601\/bpr.2024.240018","volume":"10","author":"H Peng","year":"2024","unstructured":"Peng H, Zhang Y, Luo Q, Wang X, You H. Unfolding rates of 1:1 and 2:1 complex of CX-5461 and c-<i>MYC<\/i> promoter G-quadruplexes revealed by single-molecule force spectroscopy. Biophys Rep. 2024;10:180\u20139.","journal-title":"Biophys Rep"},{"key":"6473_CR74","doi-asserted-by":"publisher","first-page":"6722","DOI":"10.1021\/ja8016973","volume":"130","author":"NH Campbell","year":"2008","unstructured":"Campbell NH, Parkinson GN, Reszka AP, Neidle S. Structural basis of DNA quadruplex recognition by an acridine drug. J Am Chem Soc. 2008;130:6722.","journal-title":"J Am Chem Soc"},{"key":"6473_CR75","doi-asserted-by":"publisher","first-page":"5905","DOI":"10.1093\/nar\/gkab330","volume":"49","author":"J Dickerhoff","year":"2021","unstructured":"Dickerhoff J, Dai JX, Yang DZ. Structural recognition of the MYC promoter G-quadruplex by a quinoline derivative: insights into molecular targeting of parallel G-quadruplexes. Nucleic Acids Res. 2021;49:5905\u201315.","journal-title":"Nucleic Acids Res"},{"key":"6473_CR76","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/s41467-019-08905-8","volume":"10","author":"Y Wang","year":"2019","unstructured":"Wang Y, Yang J, Wild AT, Wu WH, Shah R, Danussi C, Riggins GJ, Kannan K, Sulman EP, Chan TA, et al. G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma. Nat Commun. 2019;10:943.","journal-title":"Nat Commun"},{"key":"6473_CR77","doi-asserted-by":"publisher","first-page":"4737","DOI":"10.1073\/pnas.1720391115","volume":"115","author":"M Udugama","year":"2018","unstructured":"Udugama M, Sanij E, Voon HPJ, Son J, Hii L, Henson JD, Chan FL, Chang FTM, Liu YM, Pearson RB, et al. Ribosomal DNA copy loss and repeat instability in ATRX-mutated cancers. Proc Natl Acad Sci USA. 2018;115:4737\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6473_CR78","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noae248","author":"S Dharmaiah","year":"2024","unstructured":"Dharmaiah S, Malgulwar PB, Johnson WE, Chen BA, Sharin V, Whitfield BT, Alvarez C, Tadimeti V, Farooqi AS, Huse JT. G-quadruplex stabilizer CX-5461 effectively combines with radiotherapy to target \u03b1-thalassemia\/mental retardation X-linked-deficient malignant glioma. Neuro-Oncology. 2024. https:\/\/doi.org\/10.1093\/neuonc\/noae248.","journal-title":"Neuro-Oncology"},{"key":"6473_CR79","doi-asserted-by":"publisher","first-page":"100856","DOI":"10.1016\/j.neo.2022.100856","volume":"35","author":"S-Y Chung","year":"2023","unstructured":"Chung S-Y, Chang Y-C, Hsu DS-S, Hung Y-C, Lu M-L, Hung Y-P, Chiang N-J, Yeh C-N, Hsiao M, Soong J, et al. A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancer. Neoplasia. 2023;35:100856.","journal-title":"Neoplasia"},{"key":"6473_CR80","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13046-018-0749-8","volume":"37","author":"G Li","year":"2018","unstructured":"Li G, Shen J, Cao J, Zhou G, Lei T, Sun Y, Gao H, Ding Y, Xu W, Zhan Z, et al. Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461. J Exp Clin Canc Res. 2018;37:78.","journal-title":"J Exp Clin Canc Res"},{"key":"6473_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107894","author":"Y-M Zhang","year":"2024","unstructured":"Zhang Y-M, Li B, Wu W-Q. Single-molecule insights into repetitive helicases. J Biol Chem. 2024. https:\/\/doi.org\/10.1016\/j.jbc.2024.107894.","journal-title":"J Biol Chem"},{"key":"6473_CR82","doi-asserted-by":"publisher","first-page":"e1008740","DOI":"10.1371\/journal.pgen.1008740","volume":"16","author":"DC Odermatt","year":"2020","unstructured":"Odermatt DC, Lee WTC, Wild S, Jozwiakowski SK, Rothenberg E, Gari K. Cancer-associated mutations in the iron-sulfur domain of FANCJ affect G-quadruplex metabolism. PLoS Genet. 2020;16:e1008740.","journal-title":"PLoS Genet"},{"key":"6473_CR83","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1158\/0008-5472.CAN-18-1877","volume":"78","author":"WW Wu","year":"2018","unstructured":"Wu WW, Rokutanda N, Takeuchi J, Lai YQ, Maruyama R, Togashi Y, Nishikawa H, Arai N, Miyoshi Y, Suzuki N, et al. HERC2 facilitates BLM and WRN helicase complex interaction with RPA to suppress G-quadruplex DNA. Can Res. 2018;78:6371\u201385.","journal-title":"Can Res"},{"key":"6473_CR84","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41598-020-79715-y","volume":"11","author":"MZ Zhu","year":"2021","unstructured":"Zhu MZ, Wu WW, Togashi Y, Liang WX, Miyoshi Y, Ohta T. HERC2 inactivation abrogates nucleolar localization of RecQ helicases BLM and WRN. Sci Rep. 2021;11:360.","journal-title":"Sci Rep"},{"key":"6473_CR85","doi-asserted-by":"publisher","first-page":"9812","DOI":"10.1038\/s41598-021-88988-w","volume":"11","author":"T Masud","year":"2021","unstructured":"Masud T, Soong C, Xu H, Biele J, Bjornson S, McKinney S, Aparicio S. Ubiquitin-mediated DNA damage response is synthetic lethal with G-quadruplex stabilizer CX-5461. Sci Rep. 2021;11:9812.","journal-title":"Sci Rep"},{"key":"6473_CR86","doi-asserted-by":"publisher","first-page":"107457","DOI":"10.1016\/j.phrs.2024.107457","volume":"209","author":"P Sitarek","year":"2024","unstructured":"Sitarek P, Merecz-Sadowska A, Sikora J, Dudzic M, Wiertek-Ploszaj N, Picot L, Sliwinski T, Kowalczyk T. Flavonoids and their derivatives as DNA topoisomerase inhibitors with anti-cancer activity in various cell models: exploring a novel mode of action. Pharmacol Res. 2024;209:107457.","journal-title":"Pharmacol Res"},{"key":"6473_CR87","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.3390\/biomedicines10112932","volume":"10","author":"S Salerno","year":"2022","unstructured":"Salerno S, Barresi E, Baglini E, Poggetti V, Taliani S, Da Settimo F. Dual targeting topoisomerase\/G-quadruplex agents in cancer therapy-an overview. Biomedicines. 2022;10:2932.","journal-title":"Biomedicines"},{"key":"6473_CR88","doi-asserted-by":"publisher","first-page":"11333","DOI":"10.1021\/bi00203a031","volume":"33","author":"PA Permana","year":"2002","unstructured":"Permana PA, Snapka RM, Shen LL, Chu DTW, Clement JJ, Plattner JJ. Quinobenoxazines: a class of novel antitumor quinolones and potent mammalian DNA topoisomerase II catalytic inhibitors. Biochemistry. 2002;33:11333\u20139.","journal-title":"Biochemistry"},{"key":"6473_CR89","doi-asserted-by":"publisher","first-page":"e65184","DOI":"10.7554\/eLife.65184","volume":"10","author":"M Bossaert","year":"2021","unstructured":"Bossaert M, Pipier A, Riou J-F, Noirot C, Nguy\u00ean L-T, Serre R-F, Bouchez O, Defrancq E, Calsou P, Britton S, et al. Transcription-associated topoisomerase 2\u03b1 (TOP2A) activity is a major effector of cytotoxicity induced by G-quadruplex ligands. eLife. 2021;10:e65184.","journal-title":"eLife"},{"key":"6473_CR90","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cell.2020.05.040","volume":"182","author":"M Olivieri","year":"2020","unstructured":"Olivieri M, Cho T, Alvarez-Quil\u00f3n A, Li KJ, Schellenberg MJ, Zimmermann M, Hustedt N, Rossi SE, Adam S, Melo H, et al. A genetic map of the response to DNA damage in human cells. Cell. 2020;182:481.","journal-title":"Cell"},{"key":"6473_CR91","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.1038\/s41467-021-26640-x","volume":"12","author":"M Pan","year":"2021","unstructured":"Pan M, Wright WC, Chapple RH, Zubair A, Sandhu M, Batchelder JE, Huddle BC, Low J, Blankenship KB, Wang Y, et al. The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma. Nat Commun. 2021;12:6468.","journal-title":"Nat Commun"},{"key":"6473_CR92","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/s41423-024-01186-2","volume":"21","author":"A Mihali\u0107","year":"2024","unstructured":"Mihali\u0107 A, \u017deleznjak J, Lisni\u0107 B, Jonji\u0107 S, Jurani\u0107 Lisni\u0107 V, Brizi\u0107 I. Immune surveillance of cytomegalovirus in tissues. Cell Mol Immunol. 2024;21:959\u201381.","journal-title":"Cell Mol Immunol"},{"key":"6473_CR93","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00134-024-07737-5","volume":"51","author":"S Fern\u00e1ndez","year":"2025","unstructured":"Fern\u00e1ndez S, Castro P, Azoulay E. What intensivists need to know about cytomegalovirus infection in immunocompromised ICU patients. Intensive Care Med. 2025;51:39\u201361.","journal-title":"Intensive Care Med"},{"key":"6473_CR94","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.tim.2022.12.003","volume":"31","author":"M Nu\u00e9valos","year":"2023","unstructured":"Nu\u00e9valos M, Garc\u00eda-R\u00edos E, Mancebo FJ, Mart\u00edn-Mart\u00edn C, P\u00e9rez-Romero P. Novel monoclonal antibody-based therapies: implications for the treatment and prevention of HCMV disease. Trends Microbiol. 2023;31:480\u201397.","journal-title":"Trends Microbiol"},{"key":"6473_CR95","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.antiviral.2018.02.014","volume":"153","author":"KN Westdorp","year":"2018","unstructured":"Westdorp KN, Terhune SS. Impact of RNA polymerase I inhibitor CX-5461 on viral kinase-dependent and -independent cytomegalovirus replication. Antiviral Res. 2018;153:33\u20138.","journal-title":"Antiviral Res"},{"key":"6473_CR96","doi-asserted-by":"publisher","first-page":"96536","DOI":"10.18632\/oncotarget.22106","volume":"8","author":"ON Kostopoulou","year":"2017","unstructured":"Kostopoulou ON, Wilhelmi V, Raiss S, Ananthaseshan S, Lindstr\u00f6m MS, Bartek J, S\u00f6derberg-Naucler C. Human cytomegalovirus and Herpes Simplex type I virus can engage RNA polymerase I for transcription of immediate early genes. Oncotarget. 2017;8:96536\u201352.","journal-title":"Oncotarget"},{"key":"6473_CR97","doi-asserted-by":"publisher","first-page":"13822","DOI":"10.18632\/oncotarget.24497","volume":"9","author":"A Gelgor","year":"2018","unstructured":"Gelgor A, Gam ze Letova, C., Yegorov, Y., Kalt, I. and Sarid, R. Nucleolar stress enhances lytic reactivation of the Kaposi\u2019s sarcoma-associated herpesvirus. Oncotarget. 2018;9:13822\u201333.","journal-title":"Oncotarget"},{"key":"6473_CR98","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1021\/acsinfecdis.9b00272","volume":"5","author":"E Butovskaya","year":"2019","unstructured":"Butovskaya E, Sold\u00e0 P, Scalabrin M, Nadai M, Richter SN. HIV-1 nucleocapsid protein unfolds stable RNA G-quadruplexes in the viral genome and is inhibited by G-quadruplex ligands. Acs Infect Dis. 2019;5:2127\u201335.","journal-title":"Acs Infect Dis"},{"key":"6473_CR99","doi-asserted-by":"publisher","first-page":"10161","DOI":"10.1021\/acs.jmedchem.2c00649","volume":"65","author":"L-Y Zhai","year":"2022","unstructured":"Zhai L-Y, Liu J-F, Zhao J-J, Su A-M, Xi X-G, Hou X-M. Targeting the RNA G-quadruplex and protein interactome for antiviral therapy. J Med Chem. 2022;65:10161\u201382.","journal-title":"J Med Chem"},{"key":"6473_CR100","doi-asserted-by":"publisher","first-page":"e29692","DOI":"10.1002\/jmv.29692","volume":"96","author":"GB Figueroa","year":"2024","unstructured":"Figueroa GB, D\u2019souza S, Pereira HS, Vasudeva G, Figueroa SB, Robinson ZE, Badmalia MD, Meier-Stephenson V, Corcoran JA, van Marle G, et al. Development of a single-domain antibody to target a G-quadruplex located on the hepatitis B virus covalently closed circular DNA genome. J Med Virol. 2024;96:e29692.","journal-title":"J Med Virol"},{"key":"6473_CR101","doi-asserted-by":"publisher","first-page":"5428","DOI":"10.1038\/s41467-024-49761-5","volume":"15","author":"JR Terrell","year":"2024","unstructured":"Terrell JR, Le TT, Paul A, Brinton MA, Wilson WD, Poon GMK, Germann MW, Siemer JL. Structure of an RNA G-quadruplex from the West Nile virus genome. Nat Commun. 2024;15:5428.","journal-title":"Nat Commun"},{"key":"6473_CR102","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.ijbiomac.2022.09.152","volume":"221","author":"L-Y Zhai","year":"2022","unstructured":"Zhai L-Y, Su A-M, Liu J-F, Zhao J-J, Xi X-G, Hou X-M. Recent advances in applying G-quadruplex for SARS-CoV-2 targeting and diagnosis: a review. Int J Biol Macromol. 2022;221:1476\u201390.","journal-title":"Int J Biol Macromol"},{"key":"6473_CR103","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/anie.202011419","volume":"60","author":"C Zhao","year":"2020","unstructured":"Zhao C, Qin G, Niu J, Wang Z, Wang C, Ren J, Qu X. Targeting RNA G-quadruplex in SARS-CoV-2: a promising therapeutic target for COVID-19? Angew Chem Int Ed. 2020;60:432\u20138.","journal-title":"Angew Chem Int Ed"},{"key":"6473_CR104","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1097\/TP.0000000000002372","volume":"102","author":"CC Dai","year":"2018","unstructured":"Dai CC, Sun MY, Wang FJ, Zhu JK, Wei YP, Guo XT, Ma SQ, Dong B, Wang GJ, Jiang F, et al. The selective RNA polymerase I inhibitor CX-5461 mitigates neointimal remodeling in a modified model of rat aortic transplantation. Transplantation. 2018;102:1674\u201383.","journal-title":"Transplantation"},{"key":"6473_CR105","doi-asserted-by":"publisher","first-page":"926317","DOI":"10.3389\/fphar.2022.926317","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Zheng Z, Cui X, Dai C, Li J, Zhang Q, Cheng M, Jiang F. A transcriptional program associated with cell cycle regulation predominates in the anti-inflammatory effects of CX-5461 in macrophage. Front Pharmacol. 2022;13:926317.","journal-title":"Front Pharmacol"},{"key":"6473_CR106","doi-asserted-by":"publisher","first-page":"106120","DOI":"10.1016\/j.phrs.2022.106120","volume":"177","author":"G Pan","year":"2022","unstructured":"Pan G, Zhang J, Han Y, Chen Y, Guo X, Cui X, Cheng M, Gao H, Wang J, Jiang F. CX-5461 is a potent immunosuppressant which inhibits T cell-mediated alloimmunity via p53-DUSP5. Pharmacol Res. 2022;177:106120.","journal-title":"Pharmacol Res"},{"key":"6473_CR107","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/exd.14682","volume":"32","author":"X Wu","year":"2023","unstructured":"Wu X, Yin Q, Wang J, Dai C, Wang J, Guo X, Jiang F. Novel RNA polymerase I inhibitor CX-5461 suppresses imiquimod-induced experimental psoriasis. Exp Dermatol. 2023;32:91\u20139.","journal-title":"Exp Dermatol"},{"key":"6473_CR108","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/ATVBAHA.116.308401","volume":"37","author":"Q Ye","year":"2017","unstructured":"Ye Q, Pang S, Zhang W, Guo X, Wang J, Zhang Y, Liu Y, Wu X, Jiang F. Therapeutic targeting of RNA polymerase I with the small-molecule CX-5461 for prevention of arterial injury-induced neointimal hyperplasia. Arterioscler Thromb Vasc Biol. 2017;37:476\u201384.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6473_CR109","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, et al. Expanded GGGGCC Hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245\u201356.","journal-title":"Neuron"},{"key":"6473_CR110","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3233\/JAD-121456","volume":"34","author":"I Le Ber","year":"2013","unstructured":"Le Ber I, Camuzat A, Guillot-Noel L, Hannequin D, Lacomblez L, Golfier V, Puel M, Martinaud O, Deramecourt V, Rivaud-Pechoux S, et al. C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing. J Alzheimers Dis. 2013;34:485\u201399.","journal-title":"J Alzheimers Dis"},{"key":"6473_CR111","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"AE Renton","year":"2011","unstructured":"Renton AE, Majounie E, Waite A, Sim\u00f3n-S\u00e1nchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, et al. A hexanucleotide repeat expansion in C9ORF72 Is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257\u201368.","journal-title":"Neuron"},{"key":"6473_CR112","doi-asserted-by":"publisher","first-page":"RP105446","DOI":"10.7554\/eLife.105446.3","volume":"14","author":"L Kallweit","year":"2025","unstructured":"Kallweit L, Hamlett ED, Saternos H, Gilmore A, Granholm A-C, Horowitz S. Chronic RNA G-quadruplex accumulation in aging and Alzheimer\u2019s disease. eLife. 2025;14:RP105446.","journal-title":"eLife"},{"key":"6473_CR113","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1039\/D4SC04453C","volume":"16","author":"H Yuan","year":"2025","unstructured":"Yuan H, Yang J, Qin G, Sun Y, Zhao C, Wang C, Ren J, Qu X. Regulation of STING G-quadruplex for rescuing cellular senescence and A\u03b2 phagocytic capacity of microglia. Chem Sci. 2025;16:693\u20139.","journal-title":"Chem Sci"},{"key":"6473_CR114","doi-asserted-by":"publisher","first-page":"e0203374","DOI":"10.1371\/journal.pone.0203374","volume":"13","author":"KD Allen","year":"2018","unstructured":"Allen KD, Regier MJ, Hsieh C, Tsokas P, Barnard M, Phatarpekar S. Learning-induced ribosomal RNA is required for memory consolidation in mice-evidence of differentially expressed rRNA variants in learning and memory (vol 13, e0203374, 2018). PLoS ONE. 2018;13:e0203374.","journal-title":"PLoS ONE"},{"key":"6473_CR115","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/jnc.13504","volume":"136","author":"F Capitano","year":"2016","unstructured":"Capitano F, Gargiuli C, Angerilli A, Maccaroni K, Pelliccia F, Mele A, Camilloni G. RNA polymerase I transcription is modulated by spatial learning in different brain regions. J Neurochem. 2016;136:706\u201316.","journal-title":"J Neurochem"},{"key":"6473_CR116","doi-asserted-by":"publisher","first-page":"e202305645","DOI":"10.1002\/anie.202305645","volume":"62","author":"LY Liu","year":"2023","unstructured":"Liu LY, Ma TZ, Zeng YL, Liu WT, Zhang H, Mao ZW. Organic-platinum hybrids for covalent binding of g-quadruplexes: structural basis and application to cancer immunotherapy. Angew Chem Int Edit. 2023;62:e202305645.","journal-title":"Angew Chem Int Edit"},{"key":"6473_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-01112-7","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Zhang C. Regulation of cGAS\u2013STING signalling and its diversity of cellular outcomes. Nat Rev Immunol. 2025. https:\/\/doi.org\/10.1038\/s41577-024-01112-7.","journal-title":"Nat Rev Immunol"},{"key":"6473_CR118","doi-asserted-by":"publisher","first-page":"6673","DOI":"10.1093\/nar\/gkab500","volume":"49","author":"G Miglietta","year":"2021","unstructured":"Miglietta G, Russo M, Duardo RC, Capranico G. G-quadruplex binders as cytostatic modulators of innate immune genes in cancer cells. Nucleic Acids Res. 2021;49:6673\u201386.","journal-title":"Nucleic Acids Res"},{"key":"6473_CR119","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41419-024-07215-2","volume":"15","author":"PS Li","year":"2024","unstructured":"Li PS, Zhou DW, Xie YM, Yuan Z, Huang MZ, Xu GP, Huang JF, Zhuang ZK, Luo YX, Yu HC, et al. Targeting G-quadruplex by TMPyP4 for inhibition of colorectal cancer through cell cycle arrest and boosting anti-tumor immunity. Cell Death Dis. 2024;15:816.","journal-title":"Cell Death Dis"},{"key":"6473_CR120","doi-asserted-by":"publisher","first-page":"116361","DOI":"10.1016\/j.ejmech.2024.116361","volume":"269","author":"X-D Wang","year":"2024","unstructured":"Wang X-D, Liu Y-S, Chen M-D, Hu M-H. Discovery of a triphenylamine-based ligand that targets mitochondrial DNA G-quadruplexes and activates the cGAS-STING immunomodulatory pathway. Eur J Med Chem. 2024;269:116361.","journal-title":"Eur J Med Chem"},{"key":"6473_CR121","doi-asserted-by":"publisher","first-page":"e14501","DOI":"10.15252\/emmm.202114501","volume":"14","author":"FJ Groelly","year":"2022","unstructured":"Groelly FJ, Porru M, Zimmer J, Benainous H, De Visser Y, Kosova AA, Di Vito S, Serra V, Ryan A, Leonetti C, et al. Anti-tumoural activity of the G-quadruplex ligand pyridostatin against BRCA1\/2-deficient tumours. EMBO Mol Med. 2022;14:e14501.","journal-title":"EMBO Mol Med"},{"key":"6473_CR122","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.3390\/cells11162482","volume":"11","author":"F Napolitano","year":"2022","unstructured":"Napolitano F, Di Somma S, Castellano G, Amato J, Pagano B, Randazzo A, Portella G, Malfitano AM. Combination of dl922-947 oncolytic adenovirus and G-quadruplex binders uncovers improved antitumor activity in breast cancer. Cells. 2022;11:2482.","journal-title":"Cells"},{"key":"6473_CR123","doi-asserted-by":"publisher","first-page":"9756","DOI":"10.1039\/D4SC00643G","volume":"15","author":"TZ Ma","year":"2024","unstructured":"Ma TZ, Liu LY, Zeng YL, Ding K, Zhang H, Liu WT, Cao Q, Xia W, Xiong XS, Wu C, et al. G-quadruplex-guided cisplatin triggers multiple pathways in targeted chemotherapy and immunotherapy. Chem Sci. 2024;15:9756\u201374.","journal-title":"Chem Sci"},{"key":"6473_CR124","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noae248","author":"S Dharmaiah","year":"2024","unstructured":"Dharmaiah S, Malgulwar PB, Johnson WE, Chen BA, Sharin V, Whitfield BT, Alvarez C, Tadimeti V, Farooqi AS, Huse JT. G-quadruplex stabilizer CX-5461 effectively combines with radiotherapy to target ATRX-deficient malignant glioma. Neuro Oncol. 2024. https:\/\/doi.org\/10.1093\/neuonc\/noae248.","journal-title":"Neuro Oncol"},{"key":"6473_CR125","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1038\/s41598-022-07928-4","volume":"12","author":"SL Lehman","year":"2022","unstructured":"Lehman SL, Schwartz KR, Maheshwari S, Camphausen K, Tofilon PJ. CX-5461 induces radiosensitization through modification of the DNA damage response and not inhibition of RNA polymerase I. Sci Rep. 2022;12:4059.","journal-title":"Sci Rep"},{"key":"6473_CR126","doi-asserted-by":"publisher","first-page":"1453753","DOI":"10.3389\/fimmu.2024.1453753","volume":"15","author":"HX Li","year":"2024","unstructured":"Li HX, Gong YW, Yan PJ, Xu Y, Qin G, Wen WP, Teng FY. Revolutionizing head and neck squamous cell carcinoma treatment with nanomedicine in the era of immunotherapy. Front Immunol. 2024;15:1453753.","journal-title":"Front Immunol"},{"key":"6473_CR127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2018.07.025","volume":"286","author":"AWY Leung","year":"2018","unstructured":"Leung AWY, Anantha M, Dragowska WH, Wehbe M, Bally MB. Copper-CX-5461: a novel liposomal formulation for a small molecule rRNA synthesis inhibitor. J Control Release. 2018;286:1\u20139.","journal-title":"J Control Release"},{"key":"6473_CR128","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jconrel.2022.03.004","volume":"345","author":"AWY Leung","year":"2022","unstructured":"Leung AWY, Chen KTJ, Ryan GM, Anantha M, Wretham N, Nosrati Z, Heroux D, Wang L, Chow N, Dai Z, et al. DMPC\/Chol liposomal copper CX5461 is therapeutically superior to a DSPC\/Chol formulation. J Control Release. 2022;345:75\u201390.","journal-title":"J Control Release"},{"key":"6473_CR129","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1186\/s12951-024-02856-z","volume":"22","author":"M Zhang","year":"2024","unstructured":"Zhang M, Xu X, Su L, Zeng Y, Lin J, Li W, Zou Y, Li S, Lin B, Li Z, et al. Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice. J Nanobiotechnol. 2024;22:607.","journal-title":"J Nanobiotechnol"},{"key":"6473_CR130","doi-asserted-by":"publisher","first-page":"e2305826","DOI":"10.1002\/adma.202305826","volume":"36","author":"HY Wei","year":"2024","unstructured":"Wei HY, Yi K, Li FF, Li D, Yang JZ, Shi R, Jin YY, Wang HX, Ding JX, Tao Y, et al. Multimodal tetrahedral DNA nanoplatform for surprisingly rapid and significant treatment of acute liver failure. Adv Mater. 2024;36:e2305826.","journal-title":"Adv Mater"},{"key":"6473_CR131","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1093\/nar\/gkq166","volume":"38","author":"MM Dailey","year":"2010","unstructured":"Dailey MM, Miller MC, Bates PJ, Lane AN, Trent JO. Resolution and characterization of the structural polymorphism of a single quadruplex-forming sequence. Nucleic Acids Res. 2010;38:4877\u201388.","journal-title":"Nucleic Acids Res"},{"key":"6473_CR132","doi-asserted-by":"publisher","first-page":"1217769","DOI":"10.3389\/fmolb.2023.1217769","volume":"10","author":"A Van den Avont","year":"2023","unstructured":"Van den Avont A, Sharma-Walia N. Anti-nucleolin aptamer AS1411: an advancing therapeutic. Front Mol Biosci. 2023;10:1217769.","journal-title":"Front Mol Biosci"},{"key":"6473_CR133","doi-asserted-by":"publisher","first-page":"7781","DOI":"10.3390\/ijms21207781","volume":"21","author":"AM Ogloblina","year":"2020","unstructured":"Ogloblina AM, Iaccarino N, Capasso D, Di Gaetano S, Garzarella EU, Dolinnaya NG, Yakubovskaya MG, Pagano B, Amato J, Randazzo A. Toward G-quadruplex-based anticancer agents: biophysical and biological studies of novel AS1411 derivatives. Int J Mol Sci. 2020;21:7781.","journal-title":"Int J Mol Sci"},{"key":"6473_CR134","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.bbagen.2016.12.015","volume":"1861","author":"PJ Bates","year":"2017","unstructured":"Bates PJ, Reyes-Reyes EM, Malik MT, Murphy EM, O\u2019Toole MG, Trent JO. G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: Uses and mechanisms. Biochim Biophys Acta. 2017;1861:1414\u201328.","journal-title":"Biochim Biophys Acta"},{"key":"6473_CR135","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12951-022-01240-z","volume":"20","author":"X Tong","year":"2022","unstructured":"Tong X, Ga L, Ai J, Wang Y. Progress in cancer drug delivery based on AS1411 oriented nanomaterials. J Nanobiotechnol. 2022;20:57.","journal-title":"J Nanobiotechnol"},{"key":"6473_CR136","doi-asserted-by":"publisher","first-page":"7945","DOI":"10.1038\/s41598-019-44388-9","volume":"9","author":"J Carvalho","year":"2019","unstructured":"Carvalho J, Paiva A, Campello MPC, Paulo A, Mergny JL, Salgado GF, Queiroz JA, Cruz C. Aptamer-based targeted delivery of a G-quadruplex ligand in cervical cancer cells. Sci Rep. 2019;9:7945.","journal-title":"Sci Rep"},{"key":"6473_CR137","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.actbio.2018.08.035","volume":"79","author":"Y Duo","year":"2018","unstructured":"Duo Y, Yang M, Du Z, Feng C, Xing C, Wu Y, Xie Z, Zhang F, Huang L, Zeng X, et al. CX-5461-loaded nucleolus-targeting nanoplatform for cancer therapy through induction of pro-death autophagy. Acta Biomater. 2018;79:317\u201330.","journal-title":"Acta Biomater"},{"key":"6473_CR138","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1093\/nar\/gki609","volume":"33","author":"JL Huppert","year":"2005","unstructured":"Huppert JL, Balasubramanian S. Prevalence of quadruplexes in the human genome. Nucleic Acids Res. 2005;33:2908\u201316.","journal-title":"Nucleic Acids Res"},{"key":"6473_CR139","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41588-023-01602-9","volume":"56","author":"GCC Koh","year":"2024","unstructured":"Koh GCC, Boushaki S, Zhao SJ, Pregnall AM, Sadiyah F, Badja C, Memari Y, Georgakopoulos-Soares I, Nik-Zainal S. The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cells. Nat Genet. 2024;56:23\u20136.","journal-title":"Nat Genet"},{"key":"6473_CR140","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1039\/D2CS00049K","volume":"52","author":"KP Nandhini","year":"2023","unstructured":"Nandhini KP, Shaer DA, Albericio F, de la Torre BG. The challenge of peptide nucleic acid synthesis. Chem Soc Rev. 2023;52:2764\u201389.","journal-title":"Chem Soc Rev"},{"key":"6473_CR141","doi-asserted-by":"publisher","first-page":"7198","DOI":"10.1002\/anie.201201176","volume":"51","author":"T Ishizuka","year":"2012","unstructured":"Ishizuka T, Yang J, Komiyama M, Xu Y. G-Rich sequence-specific recognition and scission of human genome by PNA\/DNA Hybrid G-quadruplex formation. Angew Chem Int Edit. 2012;51:7198\u2013202.","journal-title":"Angew Chem Int Edit"},{"key":"6473_CR142","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1021\/ja028323d","volume":"125","author":"B Datta","year":"2003","unstructured":"Datta B, Schmitt C, Armitage BA. Formation of a PNA2\u2212DNA2Hybrid Quadruplex. J Am Chem Soc. 2003;125:4111\u20138.","journal-title":"J Am Chem Soc"},{"key":"6473_CR143","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1021\/ja031508f","volume":"126","author":"Y Krishnan-Ghosh","year":"2004","unstructured":"Krishnan-Ghosh Y, Stephens E, Balasubramanian S. A PNA4 quadruplex. J Am Chem Soc. 2004;126:5944\u20135.","journal-title":"J Am Chem Soc"},{"key":"6473_CR144","doi-asserted-by":"publisher","first-page":"102670","DOI":"10.1016\/j.jbc.2022.102670","volume":"298","author":"W-Q Wu","year":"2022","unstructured":"Wu W-Q, Zhang X, Bai D, Shan S-W, Guo L-J. Mechanistic insights into poly(C)-binding protein hnRNP K resolving i-motif DNA secondary structures. J Biol Chem. 2022;298:102670.","journal-title":"J Biol Chem"},{"key":"6473_CR145","doi-asserted-by":"publisher","first-page":"7570","DOI":"10.1093\/nar\/gkp840","volume":"37","author":"MI Onyshchenko","year":"2009","unstructured":"Onyshchenko MI, Gaynutdinov TI, Englund EA, Appella DH, Neumann RD, Panyutin IG. Stabilization of G-quadruplex in the BCL2 promoter region in double-stranded DNA by invading short PNAs. Nucleic Acids Res. 2009;37:7570\u201380.","journal-title":"Nucleic Acids Res"},{"key":"6473_CR146","doi-asserted-by":"publisher","first-page":"7114","DOI":"10.1093\/nar\/gkr259","volume":"39","author":"MI Onyshchenko","year":"2011","unstructured":"Onyshchenko MI, Gaynutdinov TI, Englund EA, Appella DH, Neumann RD, Panyutin IG. Quadruplex formation is necessary for stable PNA invasion into duplex DNA of BCL2 promoter region. Nucleic Acids Res. 2011;39:7114\u201323.","journal-title":"Nucleic Acids Res"},{"key":"6473_CR147","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1093\/nar\/gkad189","volume":"51","author":"E Cadoni","year":"2023","unstructured":"Cadoni E, De Paepe L, Colpaert G, Tack R, Waegeman D, Manicardi A, Madder A. A red light-triggered chemical tool for sequence-specific alkylation of G-quadruplex and I-motif DNA. Nucleic Acids Res. 2023;51:4112\u201325.","journal-title":"Nucleic Acids Res"},{"key":"6473_CR148","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1093\/nar\/gkaa186","volume":"48","author":"M Tassinari","year":"2020","unstructured":"Tassinari M, Zuffo M, Nadai M, Pirota V, Montalvo ACS, Doria F, Freccero M, Richter SN. Selective targeting of mutually exclusive DNA G-quadruplexes: HIV-1 LTR as paradigmatic model. Nucleic Acids Res. 2020;48:4627\u201342.","journal-title":"Nucleic Acids Res"},{"key":"6473_CR149","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.1002\/chem.201705945","volume":"24","author":"S Asamitsu","year":"2018","unstructured":"Asamitsu S, Obata S, Phan AT, Hashiya K, Bando T, Sugiyama H. Simultaneous binding of hybrid molecules constructed with dual DNA-binding components to a G-quadruplex and its proximal duplex. Chem-Eur J. 2018;24:4428\u201335.","journal-title":"Chem-Eur J"},{"key":"6473_CR150","doi-asserted-by":"publisher","first-page":"113442","DOI":"10.1016\/j.yexcr.2022.113442","volume":"423","author":"MJ Kamali","year":"2023","unstructured":"Kamali MJ, Salehi M, Fatemi S, Moradi F, Khoshghiafeh A, Ahmadifard M. Locked nucleic acid (LNA): a modern approach to cancer diagnosis and treatment. Exp Cell Res. 2023;423:113442.","journal-title":"Exp Cell Res"},{"key":"6473_CR151","doi-asserted-by":"publisher","first-page":"10555","DOI":"10.1093\/nar\/gkaa720","volume":"48","author":"L Haase","year":"2020","unstructured":"Haase L, Weisz K. Locked nucleic acid building blocks as versatile tools for advanced G-quadruplex design. Nucleic Acids Res. 2020;48:10555\u201366.","journal-title":"Nucleic Acids Res"},{"key":"6473_CR152","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1093\/nar\/gkq1133","volume":"39","author":"EB Pedersen","year":"2011","unstructured":"Pedersen EB, Nielsen JT, Nielsen C, Filichev VV. Enhanced anti-HIV-1 activity of G-quadruplexes comprising locked nucleic acids and intercalating nucleic acids. Nucleic Acids Res. 2011;39:2470\u201381.","journal-title":"Nucleic Acids Res"},{"key":"6473_CR153","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1002\/chem.201001961","volume":"17","author":"D Pradhan","year":"2011","unstructured":"Pradhan D, Hansen LH, Vester B, Petersen M. Selection of G-quadruplex folding topology with LNA-modified human telomeric sequences in K+ solution. Chem-Eur J. 2011;17:2405\u201313.","journal-title":"Chem-Eur J"},{"key":"6473_CR154","doi-asserted-by":"publisher","first-page":"5897","DOI":"10.1039\/D0CC01778G","volume":"56","author":"DJY Tan","year":"2020","unstructured":"Tan DJY, Das P, Winnerdy FR, Lim KW, Phan AT. Guanine anchoring: a strategy for specific targeting of a G-quadruplex using short PNA, LNA and DNA molecules. Chem Commun. 2020;56:5897\u2013900.","journal-title":"Chem Commun"},{"key":"6473_CR155","doi-asserted-by":"publisher","first-page":"6926","DOI":"10.1021\/jacs.3c14408","volume":"146","author":"A Berner","year":"2024","unstructured":"Berner A, Das RN, Bhuma N, Golebiewska J, Abrahamsson A, Andr\u00e9asson M, Chaudhari N, Doimo M, Bose PP, Chand K, et al. G4-ligand-conjugated oligonucleotides mediate selective binding and stabilization of individual G4 DNA structures. J Am Chem Soc. 2024;146:6926\u201335.","journal-title":"J Am Chem Soc"},{"key":"6473_CR156","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/ng.3662","volume":"48","author":"R H\u00e4nsel-Hertsch","year":"2016","unstructured":"H\u00e4nsel-Hertsch R, Beraldi D, Lensing SV, Marsico G, Zyner K, Parry A, Di Antonio M, Pike J, Kimura H, Narita M, et al. G-quadruplex structures mark human regulatory chromatin. Nat Genet. 2016;48:1267\u201372.","journal-title":"Nat Genet"},{"key":"6473_CR157","doi-asserted-by":"publisher","first-page":"11706","DOI":"10.1093\/nar\/gkaa841","volume":"48","author":"KW Zheng","year":"2020","unstructured":"Zheng KW, Zhang JY, He YD, Gong JY, Wen CJ, Chen JN, Hao YH, Zhao Y, Tan Z. Detection of genomic G-quadruplexes in living cells using a small artificial protein. Nucleic Acids Res. 2020;48:11706\u201320.","journal-title":"Nucleic Acids Res"},{"key":"6473_CR158","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.biochi.2023.11.005","volume":"219","author":"K Tanabe","year":"2024","unstructured":"Tanabe K, Miyazaki K, Umeno H, Takemoto M, Nakano S. Basic protein- and peptide-induced stabilization of long-loop DNA G-guadruplexes. Biochimie. 2024;219:110\u20137.","journal-title":"Biochimie"},{"key":"6473_CR159","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1021\/jacs.5b08596","volume":"138","author":"B Onel","year":"2016","unstructured":"Onel B, Carver M, Wu G, Timonina D, Kalarn S, Larriva M, Yang D. A new G-quadruplex with hairpin loop immediately upstream of the human BCL2 P1 promoter modulates transcription. J Am Chem Soc. 2016;138:2563\u201370.","journal-title":"J Am Chem Soc"},{"key":"6473_CR160","doi-asserted-by":"publisher","first-page":"10689","DOI":"10.1093\/nar\/gkab739","volume":"49","author":"S Ravichandran","year":"2021","unstructured":"Ravichandran S, Razzaq M, Parveen N, Ghosh A, Kim KK. The effect of hairpin loop on the structure and gene expression activity of the long-loop G-quadruplex. Nucleic Acids Res. 2021;49:10689\u2013706.","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06473-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06473-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06473-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T14:04:26Z","timestamp":1750428266000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06473-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":160,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6473"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06473-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,18]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Typing errors have been corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have provided their consent for publication of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"457"}}